David Bach, MD is a Harvard-trained neuroscientist and Founder and CEO of Optios, Inc., a San Diego-based NeuroPerformance company that works with the world’s most elite performers – including professional athletes and hedge fund managers – using cutting-edge neuroscience to dramatically enhance their cognitive performance.
Prior to founding Optios, he was a: serial entrepreneur, venture capitalist, management consultant, scientist, physician, martial artist, and professional cellist. As an entrepreneur, David founded and built three prior companies: Touchstone Health, Empyrean Benefit Solutions, and Leprechaun HCC Management. Each of these became a $200M+ enterprise. His venture capital experience was with TA Associates in Boston.
After spending a decade maximizing his own physical and mental performance, David created Optios to bring scientific rigor to, and create commercial applications in, the rapidly expanding arena of applied neuroscience.
David attended Harvard College and Harvard Medical School. His scientific training was at The Dana-Farber Cancer Institute.